Top Trends
The signals shaping today's industrial conversation.
A compact intelligence desk tracking what readers are opening, appreciating, searching, and following across Chemocule.
read signals
liked stories
search patterns
followed topics
Influence Watch
Stories Gaining Attention
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) Funding Update
HENDERSON, Nev., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA ) is continuing its ongoing negotiation with investors from Thailand, Japan, Switzerland, Luxembourg, USA, Bulgaria, and the UAE for financing of up to 50 million US dollars. The Company has seen great interest, with most investors reaching out directly to NIKA. “We are striving to select the most suitable investor and partner for NIKA, for which reason the discussions surrounding the technical details of
MagneINNO to Showcase Fully Chelated, Unbuffered Magnesium Glycinate at SupplySide West 2026
MagneINNO will showcase 8%, 10% and 12% elemental magnesium grades, proprietary seven-method chelation verification and California-stocked commercial supply at Booth #6145. Ontario, CA, Aug. 25, 2026 (GLOBE NEWSWIRE) -- MagneINNO, a B2B supplier focused on magnesium glycinate ingredients, will showcase its magnesium glycinate ingredient platform at SupplySide West 2026 in Las Vegas, where the company will exhibit at Booth #6145. The platform includes fully chelated, unbuffered magnesium glycinat
Most Read
Reader Attention
No reading data yet.
Most Liked
Reader Approval
No like data yet.
Most Searched
Market Curiosity
Most Followed